Sign Up Today and Learn More About Belhaven Biopharma Stock
Invest in or calculate the value of your shares in Belhaven Biopharma or other pre-IPO companies through EquityZen's platform.
Belhaven Biopharma Stock
Belhaven Biopharma is a clinical trial material scale-up and production, IND preparation and filing.
About Belhaven Biopharma Stock
Founded
2021
Headquarters
Raleigh, NC, US
Industries
Science and Engineering, Health Care, Biotechnology
Belhaven Biopharma Press Mentions
Stay in the know about the latest news on Belhaven Biopharma
Belhaven Biopharma Initiates a Pivotal Biocomparability Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Nasdepi(R) vs. Epinephrine Intramuscular Injections
biospace • Oct 09, 2025
Belhaven Biopharma Initiates a Pivotal Biocomparability Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Nasdepi(R) vs. Epinephrine Intramuscular Injections
newswire • Oct 09, 2025
Belhaven Biopharma Closes Oversubscribed Series a to Fund the Development of Nasdepi(R) Program Moves Into Late Stage Clinical and Manufacturing Through NDA Approval
newswire • Aug 20, 2025
Belhaven Biopharma Closes Oversubscribed Series a to Fund...
pharmiweb • Aug 19, 2025
Dry powder formulations of epinephrine and associated methods
patents • May 04, 2025
Join now and verify your accreditation status to gain access to:
- Belhaven Biopharma Current Valuation
- Belhaven Biopharma Stock Price
- Belhaven Biopharma Management
- Available deals in Belhaven Biopharma and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Belhaven Biopharma Cap Table and Funding History by Share Class and Liquidity Preferences
- Belhaven Biopharma Revenue and Financials
- Belhaven Biopharma Highlights
- Belhaven Biopharma Business Model
- Belhaven Biopharma Risk Factors
- Belhaven Biopharma Research Report from SACRA Research
Trading Belhaven Biopharma Stock
How to invest in Belhaven Biopharma stock?
Accredited investors can buy pre-IPO stock in companies like Belhaven Biopharma through EquityZen funds. These investments are made available by existing Belhaven Biopharma shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Belhaven Biopharma stock?
Shareholders can sell their Belhaven Biopharma stock through EquityZen's private company marketplace. EquityZen's network includes over 450K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 53K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."